PharmaCyte Biotech PMCB
NASDAQ PMCB
$0.35 +0.01 (+2.94%)
At close: Oct 22, 2026 · 4:00 PM EDT

PharmaCyte Biotech (PMCB) EBITDA Margin (2010 - 2012)

Updated

PharmaCyte Biotech (PMCB) posted EBITDA Margin of -13851.65% for FY2013 (year ended Apr 30, 2013), down 10960.16 percentage points from -2891.50% in FY2012.

Analysis

PharmaCyte Biotech (PMCB) EBITDA Margin (2010 - 2012) Analysis & Trends

  • Business Quant data shows PMCB's EBITDA Margin at -2891.50% in FY2012 (-2615.56 pp) and -275.94% in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 53.49%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 32.68%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 49.01%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.02%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 33.11%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 46.01%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -124.26%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 39.16%
10 PharmaCyte Biotech 3.76 Mn -69.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2012 -5,547.89%
Jul 31, 2012 -8,217.34%
Apr 30, 2012 -7,255.87%
Jan 31, 2012 -1,998.96%
Oct 31, 2011 -2,008.53%
Jul 31, 2011 -3,272.83%
Apr 30, 2011 -420.97%
Jan 31, 2011 -194.37%
Oct 31, 2010 -68.77%
Jul 31, 2010 -259.68%
API Access

PharmaCyte Biotech EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PMCB&period=max&api_key=YOUR_API_KEY